Fig. 2From: Reversible cardiomyopathy in a patient with chronic myelomonocytic leukemia treated with decitabine/cedazuridine: a case reportRepresentative image of patient’s nuclear stress test performed 2 months after admission demonstrating no radiographic evidence of ischemiaBack to article page